Bio-Techne Corporation
TECH
$54.41
$1.492.82%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 0.25% | 6.45% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.25% | 6.45% | |||
| Cost of Revenue | 4.68% | 0.81% | |||
| Gross Profit | -1.84% | 9.32% | |||
| SG&A Expenses | -55.38% | 25.53% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -25.66% | 11.19% | |||
| Operating Income | 158.05% | -15.49% | |||
| Income Before Tax | -159.72% | -10.73% | |||
| Income Tax Expenses | -133.03% | 96.42% | |||
| Earnings from Continuing Operations | -178.26% | -35.26% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -178.26% | -35.26% | |||
| EBIT | 158.05% | -15.49% | |||
| EBITDA | 97.02% | -9.63% | |||
| EPS Basic | -179.65% | -34.83% | |||
| Normalized Basic EPS | 167.65% | -7.52% | |||
| EPS Diluted | -183.07% | -36.36% | |||
| Normalized Diluted EPS | 168.93% | -7.20% | |||
| Average Basic Shares Outstanding | -1.56% | -0.67% | |||
| Average Diluted Shares Outstanding | -2.01% | -1.05% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | -2.26% | 0.53% | |||